Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugs
- 30 April 2003
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 24 (4) , 184-191
- https://doi.org/10.1016/s0165-6147(03)00067-1
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Genetics of Parkinson's DiseaseAnnals of the New York Academy of Sciences, 2000
- Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligaseNature Genetics, 2000
- α-Synuclein in Lewy bodiesNature, 1997
- Iron and neurodegenerationPublished by Elsevier ,1996
- Oxidative stress: Free radical production in neural degenerationPharmacology & Therapeutics, 1994
- Reactive Oxygen Species and the Central Nervous SystemJournal of Neurochemistry, 1992
- Deficiencies in Complex I subunits of the respiratory chain in Parkinson's diseaseBiochemical and Biophysical Research Communications, 1989
- A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia NigraJournal of Neurochemistry, 1989
- Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian BrainsJournal of Neurochemistry, 1989
- BASAL GANGLIA DISEASEPublished by Elsevier ,1982